The effect of PPARδ ligands on catalase expression may mediate many of the functions of PPARδ, implicating it as a key target for therapeutic intervention in ROS-related cardiovascular disorders such as hypertrophy. This evidence concerns the gene CAT and cardiovascular disorder.